SCHEMBL8505259

SCHEMBL8505259

CC1C[C@@H](O)CC(N)C1O

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 6/20 0.61
SI P14410 3/20 0.34
MGAM O43451 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25753759 0.86
SCHEMBL7335564 0.83
SCHEMBL5868434 0.80 FUCA1 (0.46) FUCA1
SCHEMBL16522565 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL16526379 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL16526373 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL18940367 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL19522642 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL16522590 0.79 FUCA1 (0.61) FUCA1SIMGAM
SCHEMBL17282320 0.79 FUCA1 (0.61) FUCA1SIMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704864-B9 Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer. KTB TUMORFORSCHUNGS GMBH (DE) 2012-09-19 EP disclosed
EP-1704864-B1 Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer. KTB TUMORFORSCHUNGS GMBH (DE) 2012-05-23 EP disclosed